http://www.draximage.com/Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, QuAİbec. [English, French and Spanish]Cancer > Research and DevelopmentDraxImage High Quality Radiopharmaceuticals - a division of DRAXIS Speciality Pharmaceuticals Inc. A Jubilant Organosys Company.
At DRAXIMAGE, we are passionately dedicated to the field of Nuclear medicine. Our mission is to discover, develop, manufacture and market innovative diagnostic and therapeutic radiopharmaceuticals and other technologies used in our field of expertise.
DTPA+, Gluceptate, MAA, MDP+ and Sestamibi kitsDraxisDraxis PharmaDraximage
Researches and develops diagnostics and anticancer therapy in humans and other diseases associated with control of cell growth. Laboratories in Oxford, Boulder and Farmingdale, headquartered in Melville, New York. (Nasdaq: OSIP)
Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR)
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.